CM-Path Quality Assurance Workshop

A one day workshop was held by the NCRI CM-Path (Cellular Molecular Pathology) initiative on 21st March 2017 in London on quality assurance in clinical trials. Key representatives from NHS and academic pathology, the research community and industry came together to discuss issues related to quality assurance in clinical trials and how to ensure that laboratories and pathologists undertaking clinical trial work were aware of the current regulatory framework governing clinical trial laboratories, what training is appropriate for pathologists undertaking clinical trial work and how to ensure that any laboratory work is both reproducible and accurate.

Find a list of the workshop attendees below (includes list of people that aided the paper’s after the workshop):

  • Clare Verrill, Nuffield Department of Surgical Sciences, University of Oxford, and Oxford NIHR Biomedical Research Centre, Oxford
  • Emily Howlett, CRUK
  • Laura Moretti, Institute of Cancer Research Clinical Trials and Statistics Unit, The Institute of Cancer Research
  • Maria De Silva, Sectra Ltd.
  • Newton Wong, Department of Cellular Pathology, Southmead Hospital, Bristol
  • Sidonie Hartridge-Lambert, Bristol-Myers Squibb, London
  • Joseph Beecham, Nanostring, Washington, USA
  • Stephanie Traub, CRUK
  • Sidath Katugampola, CRUK
  • Sarah Blagden, University of Oxford
  • James Morden,  Institute of Cancer Research Clinical Trials and Statistics Unit, The Institute of Cancer Research
  • Manuel Rodriguez-Justo, Department of Gastroenterology, University College Hospitals London, London
  • Maggie Cheang, Institute of Cancer Research Clinical Trials and Statistics Unit, The Institute of Cancer Research
  • Gabriella Rees, John Radcliffe Hospital, Oxford
  • Manuel Salto-Tellez, Northern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Queens University, Belfast
  • Nicholas West,Leeds Institute of Medical Research at St. James’, University of Leeds
  • Ilaria Mirabile, CRUK
  • Max Robinson, Centre for Oral Health Research, Newcastle University
  • Robert Pell, Nuffield Department of Surgical Sciences, University of Oxford, and Oxford NIHR Biomedical Research Centre
  • David Snead, Department of Pathology, University Hospitals Coventry and Warwickshire, Coventry
  • Philip Elliott, Centre for Tumour Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry
  • Gareth J Thomas, Faculty of Medicine Cancer Sciences Unit, Southampton University
  • Philip Sloan, Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne
  • Clare Craig, Genomics England
  • Louise J Jones,  Centre for Tumour Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, London
  • Jacqueline James,School of Medicine, Dentistry and Biomedical Sciences, Centre for CancerResearch and Cell Biology, Institute for Health Sciences, Queens University Belfast
  • Owen J Driskell, Department of Clinical Biochemistry, University Hospitals of North Midlands and  Institute for Applied Clinical Sciences, University of Keele, Stoke-on-Trent, Staffordshire; UK National Institute for Health Research
    Clinical Research Network West Midlands
  • Andy Hall, Newcastle University
  • Nasir Rajpoot, Department of Computer Science, University of Warwick

See the three publications to have come out of the workshop below:

» Read the paper about Quality assurance guidance for scoring and reporting for pathologists and labs here (PDF)

» Read the paper about the use of digital pathology and image analysis in clinical trials here (PDF)

» Read the paper about training and accreditation standards for pathologists undertaking clinical trial work here (PDF)